Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fair, D. E.
Right arrow Articles by Aukema, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fair, D. E.
Right arrow Articles by Aukema, H. M.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:1504-1507, June 2004


Nutrient Metabolism
Research Communication

Dietary Soy Protein Attenuates Renal Disease Progression After 1 and 3 Weeks in Han:SPRD-cy Weanling Rats1,2

Denise E. Fair*, Malcolm R. Ogborn*,{dagger}, Hope A. Weiler*,{dagger}, Neda Bankovic-Calic{dagger}, Evan P. Nitschmann{dagger}, Shirley C. Fitzpatrick-Wong* and Harold M. Aukema*,{dagger},3

Departments of * Human Nutritional Sciences and {dagger} Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, R3T 2N2, Canada

3To whom correspondence should be addressed. E-mail: aukema{at}umanitoba.ca.

Compared with casein, dietary soy protein slows disease progression in animal models of chronic renal injury. To determine whether dietary soy protein feeding can alter early disease progression, male Han:SPRD-cy rats (n = 87) in a very early stage of chronic kidney disease were fed soy protein compared with casein-based diets for 1 or 3 wk. Kidneys were assessed for fibrosis, cyst growth, fatty acid composition and prostaglandin E2 (PGE2) production. Soy protein feeding significantly reduced renal fibrosis by 22% (P = 0.0347) and 38% (P = 0.0102) after 1 and 3 wk of diet, and cyst growth was 34% lower after 3 wk (P < 0.0001). Kidney 18:2(n-6) levels were reduced in normal and diseased rats after as little as 1 wk of consuming the soy protein diet. Dietary soy protein also partially ameliorated the suppression of PGE2 production observed in diseased kidneys. Compared with diseased kidneys from casein-fed rats, ex vivo PGE2 release was 31–32% higher after 1 (P = 0.0281) and 3 (P = 0.0189) wk of dietary soy protein consumption. Hence, the first signs of a beneficial soy protein effect were observed after 1 wk of feeding, with further improvements evident after 3 wk. These data demonstrate that dietary soy protein compared with casein delays disease progression in an early stage of chronic kidney disease.


KEY WORDS: • dietary soy protein • chronic kidney disease • early intervention







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by American Society for Nutrition